Intuitive Surgical (ISRG)
443.85
+15.73 (3.67%)
NASDAQ · Last Trade: Oct 22nd, 4:58 PM EDT
News & Press Releases
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Boughtfool.com
Ark Invest bought into some market laggards on Wednesday.
Via The Motley Fool · October 22, 2026
Intuitive Surgical Stock: Margin Hit Masks Strong Q3 Growth Storymarketbeat.com
Intuitive Surgical posted Q3 margin impairments from a legal settlement and pricing changes, but revenue grew 21.5%, guidance firmed, and analysts and institutions remain bullish on ISRG.
Via MarketBeat · October 22, 2026
S&P 500 Unusual Volume Movers: Oct. 21, 2026chartmill.com
Via Chartmill · October 21, 2026
Intuitive Surgical: 3 Key Takeaways for Long-Term Investorsfool.com
Resolving a major litigation settlement while expanding into cost-sensitive outpatient centers positions the company for sustained procedure growth.
Via The Motley Fool · October 21, 2026
Robotics Stocks Diverge as AI and Semiconductor Automation Leaders Pull Aheadchartmill.com
Via Chartmill · October 9, 2026
Intuitive Surgical (NASDAQ:ISRG) Combines Strong Growth With a Constructive Technical Setupchartmill.com
Via Chartmill · October 8, 2026
Intuitive Surgical (ISRG) Q3 2026 Earnings Call Transcriptfool.com
Revenue hit $3.05 billion as procedure volumes surged and system placements accelerated.
Via The Motley Fool · October 21, 2026
S&P 500 Gap Movers: Oct. 21, 2026 Sessionchartmill.com
Via Chartmill · October 21, 2026
ISRG Q3 deep dive: margin pressure overshadows strong adoption and international growth
Medical technology company Intuitive Surgical (NASDAQ:ISRG) beat Wall Street’s revenue expectations in Q3 2026, with sales up 21.7% year on year to $3.05 bil...
Via StockStory · October 21, 2026
S&P 500 Premarket Movers on Oct. 21: Tech Hardware and AI Suppliers Gain, Health Care Declineschartmill.com
Via Chartmill · October 21, 2026
What Intuitive Surgical (ISRG) Said on Its Q3 Earnings Callmarketbeat.com
Intuitive Surgical (NASDAQ:ISRG) reported third-quarter 2026 revenue growth of 22% to just over $3 billion as procedure growth, system placements and adoption of newer platforms supported results. The company said 84% of quarterly revenue was recurring revenue, while non-GAAP earnings per share rose
Via MarketBeat · October 20, 2026
Intuitive Surgical (NASDAQ:ISRG) Reports Upbeat Q3 2026 But Stock Drops 12.7%
Medical technology company Intuitive Surgical (NASDAQ:ISRG) beat Wall Street’s revenue expectations in Q3 2026, with sales up 21.7% year on year to $3.05 bil...
Via StockStory · October 20, 2026
S&P 500 After-Hours Movers: Oct. 20 Gainers and Declinerschartmill.com
Via Chartmill · October 20, 2026
After-Hours Movers: Postmarket Gainers and Loserschartmill.com
Via Chartmill · October 20, 2026
Intuitive Announces Third Quarter Earnings
SUNNYVALE, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended September 30, 2026.
By Intuitive Surgical, Inc. · Via GlobeNewswire · October 20, 2026
3 Wall Street Analysts See Intuitive Surgical Hitting $500. Here's the Bull Case.fool.com
Robotic surgery is growing, procedures are climbing, and da Vinci 5 is rolling out. Is Intuitive Surgical's premium valuation worth paying?
Via The Motley Fool · October 19, 2026
Intuitive Surgical Earnings: What To Look For From ISRG
Medical technology company Intuitive Surgical (NASDAQ:ISRG) will be announcing earnings results this Tuesday after market hours. Here’s what investors should...
Via StockStory · October 18, 2026
Intuitive Surgical (ISRG) Stock Is Down 25% Year to Date. History Says Patient Investors Get Rewarded.fool.com
I'm a shareholder, myself, with no plans to sell.
Via The Motley Fool · October 17, 2026
Surgical Precision, Sustainable Returns: Johnson & Johnson Secures its Cash Flow Runwaymarketbeat.com
Johnson & Johnson posted Q3 revenue growth of 5.9% to $25.4 billion, raised guidance, and gained analyst support as its OTTAVA surgical system and talc settlement shape its long-term outlook.
Via MarketBeat · October 13, 2026
Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026?fool.com
Abbott trades at a 18x forward P/E with $7.4B in free cash flow, while Intuitive Surgical commands a 39x multiple backed by zero debt and 20% revenue growth.
Via The Motley Fool · October 12, 2026
4 Healthcare Stocks Worth Owning for the Next Decadefool.com
Two healthcare stocks that are leading their niches, and two that investors aren't giving enough credit to in the same niches.
Via The Motley Fool · October 12, 2026
5 Companies Fighting for Control of the Next Robotics Boomfool.com
Physical AI is moving from software into machines, but the winners may come from very different layers. See which business models have the strongest growth, monetization, and durability.
Via The Motley Fool · October 10, 2026
Prediction: Johnson & Johnson Will Be a Faster-Growing Company by 2030 Than Most Investors Expectfool.com
Don't underestimate this healthcare giant.
Via The Motley Fool · October 8, 2026
2 Profitable Stocks with Exciting Potential and 1 We Question
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Via StockStory · October 8, 2026
2 Beaten-Down Stocks Worth Buying and Holding for the Next Decadefool.com
These companies haven't said their last words.
Via The Motley Fool · October 5, 2026